Life Science Research Tools

Format: 2016-08-25
Format: 2016-08-25
July 19, 2016 | 83 Pages | SKU: IRTNTR10069

Overview of the global tissue banking market

Technavio’s market research analyst predicts the global tissue banking market to grow at a CAGR of around 5% by 2020. The market is witnessing several trends such as shift in public perception toward cord tissue and blood storage, improving techniques for the use of cord tissues in cellular therapy, and potential cure for cancers, blood disorders, and immune and genetic diseases. Tissue banks are used for storing umbilical cord tissues and blood, as these contain different types of stem cells, each with the potential to treat various injuries and diseases. Another development gaining grounds in the market is the use of automated tissue banking which plays a vital role in blood fractionation, DNA extraction, labelling, and capping techniques. With the increase in the harmonization of biobanks and research collaboration, the tissue banking market is anticipated to grow positively during the forecast period.

EMEA was the major revenue contributor to the tissue banking market and accounted for around 44% of the total market share during 2015. Much of the region’s growth is due to the presence of many established biobanks that offer tissue samples for research and therapeutic purposes. Several networking programs of tissue banks have resulted in the establishment of new tissue banks providing large sample storage capacity. With the newly established biobanks collaborating with each other to increase the existing tissue banking potentials, the market in this region is anticipated to witness growth in the coming years.

Competitive landscape and key vendors

This market is highly fragmented, with the presence of both large and small vendors. The global vendors dominate the market, however, most of the product offerings of these

July 19, 2016 | 59 Pages | SKU: IRTNTR10035

Overview of the global lyophilization equipment and services market

Market research analysts at Technavio have predicted that the global lyophilization equipment and services market will grow steadily at a CAGR of more than 8% by 2020. Pharmaceutical companies use lyophilization to improve the stability and long-term storage of labile drugs, vaccines, and injectable medicine and also for easy handling during shipping. Most of these products are unstable in aqueous solution and are lyophilized to increase their shelf life. For instance, acyclovir sodium is lyophilized to minimize the interaction of the alkaline formulation with glass materials. With injectable medicines such as vaccines becoming mandatory for children, there is an increasing demand for vaccines all across the world. Also, pharmaceutical companies have started investing in the development of new vaccines for various diseases and require the use of freeze drying machines for stabilizing vaccines.

In terms of geography, EMEA will account for a significant market share of almost 51% by 2020 and will also dominate the market throughout the forecast period. The constantly increasing number of biobanks and tissue banks in Western Europe will aid in the growth of the market. Also, regulations that mandate the adoption of advanced freeze drying equipment among the pharmaceutical and biotechnology industries will also play a major role in augmenting the market’s growth in this region in the coming years.

Competitive landscape and key vendors

Characterized by the presence of many global and local

June 17, 2016 | 70 Pages | SKU: IRTNTR9692

Overview of the cardiopulmonary stress testing systems market

According to the market research analysts at Technavio, the cardiopulmonary stress testing systems market will witness steady growth and will post a CAGR of more than 8% over the forecast period. With increasing focus on preventive diagnosis, the market for cardiopulmonary stress testing systems is expected to have a positive outlook in the coming years. In 2014, the American Heart Association estimated that cardiovascular disease-related deaths accounted for nearly 35% of the overall deaths worldwide. Awareness of these diseases and educating the public and users can help in early diagnosis, reducing the chances of developing heart diseases. For instance, the Heart Truth is a national educational program for females in the US that raises awareness about cardiac diseases and their risk factors. This program helps educate and motivate women to take necessary preventive action against the disease. Moreover, various research studies have estimated that early detection of cardiovascular diseases can help decrease the number of deaths. For example, a research study estimated that during 2001-2011, the mortality rate due to cardiopulmonary diseases declined about 39% due to early detection. Such positive results are anticipated to encourage people to undergo cardiopulmonary exercise testing to prevent future complications.

One of the significant trends bolstering this market’s growth prospects, is the increasing number of private cardiac specialty hospitals around the world. Governments of various countries are facilitating both private and community hospitals to increase the number of cardiac surgeries. Coronary artery bypass graft (CABG) surgery is one of the most frequently

June 09, 2016 | 75 Pages | SKU: IRTNTR9689

Outlook of the autoimmune disease diagnostics market

The global autoimmune disease diagnostics market is projected to witness fast-paced growth and will post an impressive CAGR of more than 6% over the forecast period. The recent advances in genomics and proteomics have accelerated biomedical research, leading to the development of novel biomarkers. Biomarkers are biochemical entities that serve as an indicator for a disease. Biomarkers linked to autoimmune diseases are being discovered and studied, which have led to the development of biomarker-specific new diagnostic products. These significant factors will drive this market’s growth in the coming years.

With increasing focus on companion diagnostic tests, the market for autoimmune disease diagnostics has a positive outlook over the next four years. Companion diagnostics help in the screening of individuals or groups who are likely to respond better to a therapeutic agent. The development of a companion diagnostic test for an autoimmune disease involves the use of a diagnostic test and monitoring of disease prognosis in individuals undergoing therapy. These tests offer insights into the therapeutic regimen's positive impact on these individuals regarding the reduction in the activity of autoimmune diseases. Several vendors are looking to tap the companion diagnostic tests market for autoimmune diseases. For instance, Crescendo Bioscience, a subsidiary of Myriad Genetics, has developed VectraDA test for detecting multi-markers for rheumatoid arthritis

June 03, 2016 | 64 Pages | SKU: IRTNTR9068

Overview of the DNA sequencing products market

Technavio’s market research analyst predicts the global DNA sequencing products market to grow stupendously at an impressive CAGR of close to 19% over the forecast period. The declining costs of DNA sequencing is likely to contribute to the growth of this market in the coming years. The Human Genome Project was the first joint initiative of various organizations to map the human genome involved over 200,000 scientists and researchers. The research scientists used the Sanger method for DNA sequencing, and it took nearly 13 years for its completion and cost USD 3 billion. Since the project’s completion, DNA sequencing technologies have undergone major transformations over the years. Scientists are using new-age technologies, such as Illumina sequencing and 454 sequencing methods for genome mapping, which costs less and takes a shorter duration for completion. Moreover, a significant reduction in sequencing costs has led many countries to invest in research and development and offer cost-effective solutions whole genome sequencing, de novo sequencing, and accurate disease diagnosis.

In this market study report, the analysts have estimated factors such as rapid advancements in personalized medicine to propel the growth prospects of this market over the predicted period. Many medical facilities in developed and developing countries are increasingly offering DNA sequencing-based medical treatment. These facilities use sophisticated technologies and tools such as rapid DNA sequencer for large-scale and quantitative assessments of genomic sequences. Moreover, DNA sequencing devices have also helped in making important research discoveries in biomedical sciences. Also, genomic testing technologies assist in identifying oncogenic variants in tumor tissues and check the responsiveness of specific drugs. This allows physicians to develop a personalized treatment program

May 05, 2016 | 65 Pages | SKU: IRTNTR7946

Market outlook of the clinical immunoassay analyzer market in the US

Technavio’s market research analyst predicts the clinical immunoassay analyzer market in the US to grow at a healthy CAGR of around 6% during the forecast period. The patients’ growing demand for high-throughput screening with the aid of immunoassays is a significant factor that augments growth in this market during the forecast period.

In this market research report, analysts estimate eminent factors, such as the rising demand for next-generation immunodiagnostics, to drive market growth during the forecast period. These immunodiagnostic devices address the needs of modern clinical laboratories and provide high quality, reliable test results for patients and clinicians. The ability of such devices to improve the workflow and turnaround time for tests is envisaged to impel market growth during the forecast period.

Competitive landscape and key vendors

This market is characterized by the presence of intense competition among several large, medium, and small-sized manufacturers. These vendors form partnerships and provide premium-priced products to maintain their market share. However, since the local vendors in this market offer products at lower prices, they can be a serious threat to large companies.

The top vendors in the market are -

  • Abbott Diagnostics
  • Beckman Coulter
  • bioMerieux
  • Roche Diagnostics
  • Siemens Healthcare Diagnostic

Other prominent vendors in the market include Affimetrix, Boditech Med, DiaSorin, DRG International, Enzo Life Sciences, EMD Millipore, Immunodiagnostics System, Inova Diagnostics, Meso Scale Discovery, Nova Century Scientific, Olympus, Quidel, Radiometer, Randox Laboratories, SDIX, Tecan, and Thermo Fisher Scientific.

Application-based segmentation of the